Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00064831 · ClinicalTrials.gov registry record · Phase 1
Black Cohosh Extract in Postmenopausal Breast Health
A Phase 1 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 1
- Development phase
- 73
- Enrollment target
NCT00064831 is a Phase 1 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 73 participants.
The verdict
NCT00064831, a Phase 1 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 73 participants
- Enrollment target
Study Summary
The purpose of the study is to determine if black cohosh extract (BCE) administration in symptomatic postmenopausal women results in estrogenic stimulation of the breast, as determined by estradiol, pS2, FSH, LH, and PSA levels in nipple aspirate fluid.
Interventions
- DRUG Black Cohosh Extract (BCE)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2003-07 |
| Est. Completion | 2007-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00064831
The ClinicalTrials.gov registry entry for NCT00064831 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Black Cohosh Extract (BCE) is the first listed.
NCT00064831 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00064831 about?
NCT00064831 is a clinical study titled "Black Cohosh Extract in Postmenopausal Breast Health". The purpose of the study is to determine if black cohosh extract (BCE) administration in symptomatic postmenopausal women results in estrogenic stimulation of the breast, as determined by estradiol, pS2, FSH, LH, and PSA levels in nipple aspirate fluid.
What is the current status of trial NCT00064831?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 73 participants. The study started on 2003-07. Estimated completion is 2007-02.
What interventions are being tested in trial NCT00064831?
The interventions under investigation include: Black Cohosh Extract (BCE) (DRUG).
Who is sponsoring clinical trial NCT00064831?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.